AMGN
34
3
HBAN
82
3
BIIB
50
4
MRK
63
3
SO
46
-5
PRU
62
2
HSY
43
2
SEE
52
2
RIG
40
2
INTC
43
6
CTAS
40
-2
NWS
60
2
KR
37
-5
ITW
37
-2
KSS
62
3
CMA
70
5
AVY
47
-7
GOOGL
47
4
MA
55
4
APD
45
-2
AMGN
34
3
HBAN
82
3
BIIB
50
4
MRK
63
3
SO
46
-5
PRU
62
2
HSY
43
2
SEE
52
2
RIG
40
2
INTC
43
6
CTAS
40
-2
NWS
60
2
KR
37
-5
ITW
37
-2
KSS
62
3
CMA
70
5
AVY
47
-7
GOOGL
47
4
MA
55
4
APD
45
-2
Financhill
Back

ProShares Short Real Estate Vs. BioMarin Pharmaceutical, Inc. Sector Stock Comparison

Sell
40

REK
ProShares Short Real Estate

Last Price:
$17.43
Seasonality Move:
0.89%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$59.30
Seasonality Move:
5.52%
Sell
40
ProShares Short Real Estate (REK) is a Sell

Is ProShares Short Real Estate a Buy, Sell or Hold?

  • The current ProShares Short Real Estate [REK] share price is $17.52. The Score for REK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • REK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REK Stock Price Chart

What is ProShares Short Real Estate's stock price today?

  • The ProShares Short Real Estate share price today is $17.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REK is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

REK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.28 Buy
Relative Strength Index (14 RSI): 63.01 Buy
Chaikin Money Flow: 8418 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.1 - 17.4) Buy
Bollinger Bands (100): (16.7 - 17.22) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

REK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.37 Buy
20-day SMA: 17.24 Buy
50-day SMA: 17.07 Buy
200-day SMA: 17.02 Buy
8-day EMA: 9.24 Buy
20-day EMA: 4.53 Buy
50-day EMA: 1.97 Buy
200-day EMA: 0.52 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

ProShares Short Real Estate Earnings Growth & REK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.73 per share.

ProShares Short Real Estate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):